We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

194 hedge funds and large institutions have $1.25B invested in Acorda Therapeutics in 2016 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 81 increasing their positions, 56 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 56

32% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 28

4% more funds holding

Funds holding: 186 → 194 (+8)

39% less capital invested

Capital invested by funds: $2.05B → $1.25B (-$809M)

75% less funds holding in top 10

Funds holding in top 10: 4 → 1 (-3)

86% less call options, than puts

Call options by funds: $1.28M | Put options by funds: $9.34M

Holders
194
Holders Change
+8
Holders Change %
+4.3%
% of All Funds
5.17%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.03%
New
37
Increased
81
Reduced
56
Closed
28
Calls
$1.28M
Puts
$9.34M
Net Calls
-$8.06M
Net Calls Change
-$4.41M

Top Buyers

1
DM
Deerfield Management
New York
+$35.6M
2
SCM
Scopia Capital Management
New York
+$24.3M
3
AL
AJO LP
Pennsylvania
+$21.9M
4
RCM
RA Capital Management
Massachusetts
+$17.2M
5
Morgan Stanley
Morgan Stanley
New York
+$13.3M

Top Sellers

1
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$50.5M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$49M
3
OIM
Oracle Investment Management
Connecticut
-$34.9M
4
PHS
PFM Health Sciences
California
-$28M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$20.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
51
VOYA Investment Management
Georgia
$3.96M -$2.66M -640 -34%
Deutsche Bank
52
Deutsche Bank
Germany
$3.76M -$789K -190 -14%
CCMH
53
Cornerstone Capital Management Holdings
New York
$3.63M +$1.01M +244 +27%
GC
54
Guggenheim Capital
Illinois
$3.31M -$614K -148 -12%
EAM
55
EverPoint Asset Management
Connecticut
$3.31M – – –
UBS AM
56
UBS AM
Illinois
$3.19M -$552K -133 -12%
SO
57
STRS Ohio
Ohio
$3.15M +$208K +50 +5%
JIM
58
Jupiter Investment Management
United Kingdom
$2.93M +$3.84M +924 New
QI
59
QS Investors
New York
$2.92M +$16.6K +4 +0.4%
Royal Bank of Canada
60
Royal Bank of Canada
Ontario, Canada
$2.74M -$187K -45 -5%
BA
61
BlackRock Advisors
Delaware
$2.56M +$369K +89 +12%
Jacobs Levy Equity Management
62
Jacobs Levy Equity Management
New Jersey
$2.51M +$3.28M +790 New
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$2.4M +$403K +97 +15%
State of New Jersey Common Pension Fund D
64
State of New Jersey Common Pension Fund D
New Jersey
$2.38M – – –
American Century Companies
65
American Century Companies
Missouri
$2.34M -$2.78M -669 -48%
CS
66
Credit Suisse
Switzerland
$2.34M +$959K +231 +46%
California Public Employees Retirement System
67
California Public Employees Retirement System
California
$2.32M +$390K +94 +15%
BG
68
BlackRock Group
United Kingdom
$2.28M +$228K +55 +8%
ACMM
69
Arbor Capital Management (Minnesota)
Minnesota
$2.18M -$228K -55 -7%
PAMU
70
Pictet Asset Management (UK)
United Kingdom
$2.13M +$87.2K +21 +4%
AllianceBernstein
71
AllianceBernstein
Tennessee
$1.99M +$45.7K +11 +2%
SI
72
Scout Investments
Missouri
$1.97M – – –
SFM
73
Sphera Funds Management
Israel
$1.93M -$2.42M -584 -49%
Wells Fargo
74
Wells Fargo
California
$1.92M +$74.7K +18 +3%
Swiss National Bank
75
Swiss National Bank
Switzerland
$1.91M +$502K +121 +24%
1 2
3
4 5

ACOR Hedge Fund Activity: Q1 2016 in Review

194 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q1 2016, worth a combined $1.25B — down 39% from $2.05B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ACOR positions and 28 closed out — a net gain of 9 holders — while 81 added to existing stakes and 56 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $35.6M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $50.5M.

  • 194 institutional investors held Acorda Therapeutics (ACOR) as of Q1 2016, up from 186 in Q4 2015.
  • Funds reported $1.25B of Acorda Therapeutics stock for Q1 2016, down 39% quarter-over-quarter.
  • 37 funds opened new Acorda Therapeutics positions in Q1 2016 and 28 closed out, a net change of +9 holders.
  • The largest Acorda Therapeutics buyer in Q1 2016 was Deerfield Management, an estimated $35.6M added.
  • The largest Acorda Therapeutics seller in Q1 2016 was Thrivent Financial for Lutherans, an estimated $50.5M sold.

Based on aggregated 13F filings for Q1 2016.